Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Feromax** is a Shayana Farm oral antianemic fixed-dose product name used for more than one formulation, so the name alone does not identify one unique chemical composition. The capsule formulation contains carbonyl iron, zinc sulfate monohydrate, and folic acid; it is indicated for anemia associated with combined iron and folate deficiency, including during pregnancy and lactation. A syrup formulation marketed under the same trade name contains iron ammonium citrate, folic acid, cyanocobalamin, copper sulfate, and magnesium sulfate. The products restore iron and hematinic micronutrients required for hemoglobin synthesis and erythropoiesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Feromax.